Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 5/20 | 0.54 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.53 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.51 |
| ▸ | CTSD | P07339 | 1/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30974275 | 0.89 | OPRM1 (0.55) | BACE1KISS1ROPRL1OPRM1OPRD1 | |
| Lignesfal SCHEMBL30151521 | 0.88 | BACE1 (0.59) | BACE1OPRM1OPRD1CTSDOPRK1 | |
| SCHEMBL30512615 | 0.86 | BACE1 (0.59) | BACE1KISS1ROPRM1OPRD1CTSD | |
| SCHEMBL30769537 | 0.86 | TFPI (0.65) | KISS1ROPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL9751908 | 0.85 | BACE1 (0.59) | BACE1CTSD | |
| SCHEMBL9751910 | 0.85 | BACE1 (0.59) | BACE1CTSD | |
| SCHEMBL29417385 | 0.85 | PTH1R (0.54) | KISS1R | |
| SCHEMBL30974224 | 0.85 | OPRL1 (0.56) | BACE1OPRL1 | |
| SCHEMBL31672201 | 0.85 | OPRM1 (0.56) | BACE1OPRM1OPRD1OPRK1 | |
| SCHEMBL31038686 | 0.84 | OPRD1 (0.58) | BACE1OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118975979-A | Stabilized peptide compositions | 缇尔索卢森公司 | 2024-11-19 | — | — | CN | claimed |
| CN-119730839-A | Stable peptide compositions and methods of using the same for treating ocular symptoms associated with moderate/severe dry eye | 缇尔索卢森公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-118975979-A | Stabilized peptide compositions | 缇尔索卢森公司 | 2024-11-19 | — | — | CN | disclosed |
| CN-110461350-B | Stabilized peptide compositions | 缇尔索卢森公司 | 2024-09-24 | — | — | CN | disclosed |